Stock Information
Biogen Inc (BIIB)
Ticker Symbol: BIIB
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $26,016.18 mil
Piotroski score: 5
PE Ratio: 19.9218
EPS (TTM): 8.8059
Revenue (TTM): $67.37 M
Dividend Yield: N/A%
ROE: 7.28%
Latest News
-
3 Stocks With Upgraded Broker Ratings As Markets Hit All-Time High
Thu, Apr 16, 2026 12:02 PM
-
Replimune cuts staff; MeiraGTx reacquires eye gene therapy
Thu, Apr 16, 2026 11:00 AM
-
This Healthcare Stock Has Made Long-Term Investors Rich -- Can It Keep Doing It?
Thu, Apr 16, 2026 9:50 AM
-
US FDA's accelerated approval for drugs needs more transparency, says research firm
Thu, Apr 16, 2026 8:02 AM
-
BIIB or TECH: Which Is the Better Value Stock Right Now?
Wed, Apr 15, 2026 3:40 PM
-
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
Wed, Apr 15, 2026 1:40 PM
-
Will Robust Medical Business Performance Fuel ABT's Q1 Earnings?
Wed, Apr 15, 2026 12:47 PM
-
Biogen (BIIB) Valuation Check After Mixed Recent Returns And Growing Focus On LEQEMBI Growth Potential
Wed, Apr 15, 2026 9:07 AM
-
Sector Update: Health Care Stocks Higher Late Afternoon
Tue, Apr 14, 2026 7:54 PM
-
Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls
Tue, Apr 14, 2026 1:53 PM
Key Financials
Financial data not available